Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2011

Conditions
Attention-Deficit/Hyperactivity Disorder (ADHD)
Interventions
BEHAVIORAL

Choice

Parent and teacher reports of child behavior and side effects observed during a 4-week trail of placebo and methylphenidate at lower, medium, and higher dosages will be summarized in a decision aid. Parent treatment preferences will be elicited and parents will receive coaching in deliberation about striking a balance between benefit and tolerable side effects. Parent will then choose the week that was best for their child and plan their next steps. Parents will also receive a consultation report that contains a physician dosage recommendation.

BEHAVIORAL

Recommendation

Parent and teacher reports of child behavior and side effects observed during a 4-week trail of placebo and methylphenidate at lower, medium, and higher dosages will be summarized in a consultation report that also contains a physician dosage recommendation.

Trial Locations (1)

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT00631280 - Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD | Biotech Hunter | Biotech Hunter